Viewing Study NCT01682720


Ignite Creation Date: 2025-12-25 @ 4:19 AM
Ignite Modification Date: 2026-03-02 @ 7:01 PM
Study NCT ID: NCT01682720
Status: COMPLETED
Last Update Posted: 2014-10-09
First Post: 2012-09-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Sofosbuvir and Ribavirin in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection
Sponsor: Gilead Sciences
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: GS-US-334-0133
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators